Cognition Therapeutics, Inc. discussed registrational program key aspects with the FDA in May and received Notice of Allowance for a patent application on June 16.
2 reports, 1 independent
Updated 00:00
Still developing
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Cognition Therapeutics, Inc. discussed registrational program key aspects with the FDA in May and received Notice of Allowance for a patent application on June 16.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.USPTO granted the patent for a novel crystalline form to Cognition Therapeutics.1 source
Patent allowance received; registrational program discussed with FDA.1 source